An interventional study of Spinal Mobilization and Standard Exercise Therapy in Non-Specific Low Back Pain, sponsored by Biruni University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Biruni University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 295 studies in Low Back Pain with a site in Turkey — 63 open to participants now, 73 under way, none of them phase 3. Low Back Pain · Turkey.
Among the 295 studies in Low Back Pain with a site in Turkey, this one is the 68th largest by planned enrollment of the 212 interventional ones that give a count, is one of 38 that started in 2026, is one of 204 with no phase, reaches primary completion later than 63 of the 72 other live ones, and was the 282nd registered.
2,929 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.
Browse Low Back Pain studies →63 of the 295 studies in Low Back Pain with a site in Turkey are open now. Recruiting first, the newest first:
Istanbul Medipol University Hospital · Sites in Turkey
Ages 45–65 · Women only
Uskudar University · Sites in Turkey
Ages 18–45
Marmara University · Sites in Turkey
Ages 18–65
Istinye University · Sites in Turkey
Ages 18–65
Mardin Artuklu University · Sites in Turkey
Ages 18–65
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
295 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 4 5
First in 2012; this study’s year is marked. 38 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is close to the median of 60 across 2,368 interventional studies indexed under Low Back Pain.
Median enrollment 50 across the 212 interventional studies, 107 across the 83 observational. Of the 197 that completed or were terminated, 1 (1%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 295 has an industry lead sponsor. The 10 most frequent:
Biruni University is the lead sponsor of 181 studies on the registry; 46 are open to participants now.
Biruni University has 4 studies filed under Low Back Pain — fewer than ten, so there is no comparison to draw.
15 of the studies in Low Back Pain with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07712406Gaziosmanpasa Research and Education HospitalUltrasound-Guided Proximal Superior Cluneal Nerve Block for Superior Cluneal Nerve Entrapment | 2026-11 |
| NCT07700589Istanbul Aydın UniversityComparison of Traditional, Synchronous, and Asynchronous Telerehabilitation in Office Workers With Chronic Nonspecific Low Back Pain | 2026-11-30 |
| NCT07809685Halic UniversityFactors Associated With Disability in Postpartum Lumbopelvic Pain | 2026-12-01 |
| NCT07856498Istanbul Medipol University HospitalPain Catastrophizing, Fear of Movement, and Physical Activity in Postmenopausal Women With Chronic Low Back Pain | 2026-12-01 |
| NCT07760103Uskudar UniversityCore Endurance Versus Segmental Stabilization Exercise in Recreational Athletes With Low Back Pain | 2026-12-01 |
Add all 15 to your calendar (.ics) → With an account.
Among the 295 studies in Low Back Pain with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Chronic non-specific low back pain is a major cause of functional disability and reduced quality of life worldwide. Although exercise therapy is widely recommended for managing chronic low back pain, the additional benefits of spinal mobilization on functional disability, pain intensity, and fear-avoidance beliefs remain unclear.
This assessor-blinded randomized controlled trial aims to investigate the effects of spinal mobilization added to standard exercise therapy on functional disability, pain intensity, fear-avoidance beliefs, and lumbar range of motion in individuals with chronic non-specific low back pain.
A total of 60 participants aged 18-60 years will be randomly allocated to either a standard exercise therapy group or a standard exercise therapy plus spinal mobilization group. Both groups will participate in a six-week standardized exercise program, while the intervention group will additionally receive non-thrust spinal mobilization once weekly.
Outcome assessments will be conducted at baseline, after the six-week intervention, and three months following treatment completion. The primary outcome will be functional disability measured using the Roland-Morris Disability Questionnaire. Secondary outcomes will include pain intensity, fear-avoidance beliefs, and lumbar range of motion.
The findings may provide evidence regarding the additional and sustained effects of spinal mobilization when combined with standard exercise therapy in individuals with chronic non-specific low back pain.
Background Chronic non-specific low back pain is one of the leading causes of disability worldwide and is associated with substantial physical, psychological, and socioeconomic burden. Exercise therapy is widely recommended as a primary conservative treatment approach, while spinal mobilization is frequently used as an adjunctive intervention. However, evidence regarding the additional and sustained benefits of spinal mobilization when combined with standardized exercise therapy remains limited.
Objective The aim of this randomized controlled trial is to investigate the effects of spinal mobilization added to standard exercise therapy on functional disability, pain intensity, fear-avoidance beliefs, and lumbar range of motion in individuals with chronic non-specific low back pain. Additionally, the study aims to evaluate whether the effects are maintained three months after treatment completion.
Methods This single-center, assessor-blinded, two-arm randomized controlled trial will include 60 participants aged 18-60 years with chronic non-specific low back pain lasting at least 12 weeks. Participants will be randomly allocated in a 1:1 ratio to either a standard exercise therapy group (n=30) or a standard exercise therapy plus spinal mobilization group (n=30).
Both groups will receive the same six-week standardized exercise and education program, consisting of three exercise sessions per week (two supervised sessions and one home-based session). Each session will last approximately 45-60 minutes and include trunk motor control exercises, strengthening exercises, lumbar mobility exercises, functional lower extremity exercises, and walking.
The intervention group will additionally receive non-thrust spinal mobilization targeting the lumbar or lumbopelvic region, performed by a trained physiotherapist once weekly for six weeks. Each mobilization session will last approximately 10-15 minutes. High-velocity, low-amplitude spinal manipulation will not be performed.
Functional disability will be assessed using the Roland-Morris Disability Questionnaire (RMDQ), pain intensity using the Visual Analog Scale (VAS), fear-avoidance beliefs using the Fear-Avoidance Beliefs Questionnaire (FABQ), and lumbar range of motion using standardized measurements.
Outcome assessments will be conducted at baseline (Week 0), immediately after the six-week intervention (Week 6), and three months after treatment completion (approximately Week 18).
The primary outcome will be functional disability measured by the RMDQ at Week 6. Secondary outcomes will include pain intensity, fear-avoidance beliefs, lumbar range of motion, treatment adherence, and adverse events.
The primary analysis will compare RMDQ scores between groups at Week 6 using analysis of covariance (ANCOVA), adjusting for baseline RMDQ scores. Repeated measurements across the three assessment points will be analyzed using an appropriate mixed-effects model.
Expected Outcomes
It is hypothesized that adding spinal mobilization to standard exercise therapy will result in greater improvements in functional disability compared with standard exercise therapy alone. The study will also investigate potential additional benefits regarding pain intensity, fear-avoidance beliefs, and lumbar range of motion, as well as the maintenance of treatment effects during the three-month follow-up period.
The criteria were revised on the registry on Nov 18, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this group will receive a standardized six-week exercise and education program. The program will consist of three exercise sessions per week, including two physiotherapist-supervised sessions and one home-based session (18 sessions in total). Each session will last approximately 45-60 minutes and include trunk motor control exercises, abdominal activation, bridging, bird-dog exercises, hip abductor strengthening, controlled lumbar mobility, sit-to-stand exercises, walking, and cool-down exercises. Exercise intensity and repetitions will be progressively adjusted according to individual tolerance. No spinal mobilization or manipulation will be performed.
Other: Standard Exercise Therapy
Participants in this group will receive the same standardized six-week exercise and education program as the active comparator group, consisting of two supervised sessions and one home-based session per week. Additionally, participants will receive non-thrust spinal mobilization targeting the lumbar or lumbopelvic region, performed by a trained physiotherapist once weekly for six weeks (six mobilization sessions in total). Each mobilization session will last approximately 10-15 minutes. The mobilization technique and target region will be selected based on clinical assessment and individual tolerance. High-velocity, low-amplitude (HVLA) spinal manipulation will not be performed.
Other: Spinal Mobilization · Other: Standard Exercise Therapy
Participants in the experimental group will receive non-thrust spinal mobilization in addition to standard exercise therapy. Mobilization will target the lumbar or lumbopelvic region and will be performed by a trained physiotherapist using Maitland-based oscillatory techniques. The target region and mobilization grade will be selected according to clinical assessment, symptom response, and individual tolerance. Mobilization will be administered once weekly for six consecutive weeks, with each session lasting approximately 10-15 minutes (six sessions in total). The mobilization technique, grade, duration, and participant response will be recorded.
Both groups will receive the same standardized six-week exercise and education program, consisting of three sessions per week (two physiotherapist-supervised sessions and one home-based session), for a total of 18 sessions. Each session will last approximately 45-60 minutes and include warm-up exercises, abdominal muscle activation, bridging, bird-dog exercises, hip abductor strengthening, controlled lumbar mobility exercises, sit-to-stand exercises, walking, and cool-down exercises. Exercise volume will be progressively increased every two weeks according to individual tolerance and movement quality. Strengthening exercises will generally progress from 2 sets of 10 repetitions to 2 sets of 15 repetitions, while walking duration will increase from 10 to 20 minutes. Exercise adherence, perceived exertion, and symptom responses will be monitored throughout the intervention.
Functional Disability Assessed Using the Roland-Morris Disability Questionnaire (RMDQ)
Functional disability will be assessed using the Roland-Morris Disability Questionnaire (RMDQ), a 24-item questionnaire designed to evaluate disability related to low back pain. Total scores range from 0 to 24, with higher scores indicating greater functional disability. The primary endpoint will be the RMDQ score at Week 6, compared between groups after adjustment for baseline RMDQ scores.
Time frame: Baseline (Week 0) and post-intervention (Week 6) and three-month follow-up (Week 18)
Pain Intensity Assessed Using the Visual Analog Scale (VAS)
Pain intensity will be assessed using a 100-mm Visual Analog Scale (VAS). Participants will rate their average low back pain intensity over the preceding seven days, ranging from 0 mm (no pain) to 100 mm (worst imaginable pain). Higher scores indicate greater pain intensity.
Time frame: Baseline (Week 0), post-intervention (Week 6), and three-month follow-up (Week 18)
Fear-avoidance beliefs measured using the Fear-Avoidance Beliefs Questionnaire (FABQ)
Fear-avoidance beliefs will be evaluated using the Fear-Avoidance Beliefs Questionnaire (FABQ), including physical activity and work subscales. Higher scores indicate greater fear-avoidance beliefs.
Time frame: Baseline (Week 0), post-intervention (Week 6), and three-month follow-up (Week 18)
Lumbar range of motion
Lumbar flexion, extension, lateral flexion, and rotation will be measured using a universal goniometer. Three measurements will be obtained for each movement, and the mean value will be used for analysis.
Time frame: Baseline (Week 0), post-intervention (Week 6), and three-month follow-up (Week 18)
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Dec 2026; primary completion for Feb 2027, 1 month later.
Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 1 month is below that.
Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: start Aug 2026 → Dec 2026, primary completion Nov 2026 → Feb 2027 and completion Nov 2026 → Apr 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.